Skip to content

Clinical trials

Drug Resistant Epilepsy trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20191
20202
20231
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting2
Completed2
Enrolling by invitation2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
UCB Biopharma SRL2
Cerebral Therapeutics LLC1
Duke University1
ES Therapeutics Australia Pty Ltd1
Genovate-NaviFUS (Australia) Pty Ltd.1
LivaNova1
UCB Biopharma S.P.R.L.1
iQure Australia Pty Ltd1
iVEAcare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy13
Seizures8
Epilepsy7
Epilepsies, Partial2
Epilepsy, Absence1
Epilepsy, Generalized1
Epilepsy, Temporal Lobe1
Myoclonic Epilepsy, Juvenile1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.